Tempus AI vs Materials Select Sector SPDR Fund — how do they compare? Tempus AI trades at $55.53 (market cap $9.93B), while Materials Select Sector SPDR Fund trades at $53.25. The key difference: Materials Select Sector SPDR Fund is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| TEM | XLB | |
|---|---|---|
Market Cap | $9.93B | — |
Sector | Broad Market / Factor | — |
52-Week High | $103.25 | $53.62 |
52-Week Low | $41.55 | $42.23 |
Enterprise Value | $10.56B | — |
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
XLB trades at $52.86, up 1.32% today, with a bullish technical signal from moving averages and neutral oscillators. The materials sector benefits from AI infrastructure demand and strong Q2 earnings momentum, as noted by Zacks Investment Research on August 6, 2026. A dividend of $0.19 is scheduled for June 2026, while recent news highlights sector resilience amid geopolitical shifts.
Outlook is positive due to cyclical recovery and AI-driven demand, but risks include pricing pressures and economic sensitivity. Analysts see limited near-term upside after recent gains, with a hold rating common. Institutional interest remains strong, supporting stability amid volatility.
Trailing returns across standard periods
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →